Treatments · Entity Annotation Prototype (beta)

4articles mentioning treatments

4treatment mentions

1distinct treatments extracted

0%of mentions human-reviewed

Active filtersEntity: Lifestyle modification ×

Lifestyle modification

This treatment is selected. Its supporting articles are shown below.

Lifestyle modification4

Articles mentioning Lifestyle modification

4 articles · page 1 of 1

Liver fibrosis in metabolic dysfunction-associated steatotic liver disease: epidemiology, risk stratification and therapeutics

bmjgast · abstract · 2026-07-02 · 1 matching annotations

75.5%

lifestyle modification FXR agonists thyroid hormone receptor-β agonists GLP-1 receptor agonists Metabolic dysfunction-associated steatotic liver disease (MASLD)fatty acid synthase inhibitors fibroblast growth factor 21 [FGF21] analogues hepatocellular carcinoma hepatic fibrosis MASH+1 more

…ated events, hepatocellular carcinoma risk and mortality. While lifestyle modification and sustained weight loss remain foundational, therapeutic inno…

IDDF2026-ABS-0436 Structured lifestyle intervention reduces early non-alcoholic fatty liver disease progression

gutjnl · abstract · 2026-06-26 · 1 matching annotations

75.5%

Lifestyle modification Non-alcoholic fatty liver disease metabolic syndrome NAFLD

…nt and strongly associated with obesity and metabolic syndrome. Lifestyle modification remains the cornerstone of management, yet real-world evidence …

Ageing liver in the era of MASLD: risks, mechanisms and treatment opportunities

flgastro · abstract · 2026-04-22 · 1 matching annotations

86.1%

lifestyle modification resmetirom glucagon-like peptide-1 receptor agonists Metabolic dysfunction-associated steatotic liver disease (MASLD)

…penia and multimorbidity. The primary therapy for MASLD remains lifestyle modification, but it requires careful fine-tuning to prevent malnutrition in…

022 From early detection to overdiagnosis: a qualitative exploration of lived experiences with prediabetes and mild diabetes in Canada

ebmed · abstract · 2025-09-02 · 1 matching annotations

76.7%

pharmacotherapy lifestyle modification type 2 diabetes prediabetes mild diabetes pre- or mild diabetes funding specialty societies

…ed as the initial approach, many participants also acknowledged pharmacotherapy as a viable option when lifestyle changes had been maximized or…